Related references
Note: Only part of the references are listed.T-cell-based breast cancer immunotherapy
Karolina Pilipow et al.
SEMINARS IN CANCER BIOLOGY (2021)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting
Nahla M. Badr et al.
PATHOBIOLOGY (2020)
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
Caroline Bergenfelz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
TGF-β1-A truly transforming growth factor in fibrosis and immunity
Monika Lodyga et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Breast cancer stem cell antigens as targets for immunotherapy
Elena Quaglino et al.
SEMINARS IN IMMUNOLOGY (2020)
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Qi Liu et al.
EBIOMEDICINE (2020)
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law et al.
CELLS (2020)
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clement Anfray et al.
CELLS (2020)
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
Ana Alcaraz-Sanabria et al.
FRONTIERS IN ONCOLOGY (2020)
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
Zhiwei Hu
SCIENTIFIC REPORTS (2020)
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu et al.
FRONTIERS IN IMMUNOLOGY (2020)
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of granulocyte colony-stimulating factor in breast cancer development: A review
Li Liu et al.
MOLECULAR MEDICINE REPORTS (2020)
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
Soo-Chin Lee et al.
CLINICAL CANCER RESEARCH (2020)
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
Laura Conti et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles-The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort
Einar Holsbo et al.
FRONTIERS IN ONCOLOGY (2020)
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
Jesus Fuentes-Antras et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer stem cell antigens as targets for new combined anti-cancer therapies
Elena Quaglino et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
Antonino Di Lorenzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Federica Finetti et al.
BIOLOGY-BASEL (2020)
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
Lori J. Goldstein et al.
BREAST CANCER RESEARCH (2020)
Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells
Chao Ni et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse
Concetta Elisa Onesti et al.
ONCOIMMUNOLOGY (2020)
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter
Roberto Ruiu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Cytokines in the Treatment of Cancer
Kevin C. Conlon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
Luca Cassetta et al.
CANCER CELL (2019)
Alteration of specific cytokine expression patterns in patients with breast cancer
Kosuke Kawaguchi et al.
SCIENTIFIC REPORTS (2019)
Role of Mast Cell-Derived Adenosine in Cancer
Yaara Gorzalczany et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Extracellular vesicles in the tumor microenvironment: old stories, but new tales
Liu Han et al.
MOLECULAR CANCER (2019)
Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer
Man Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Interaction of tumor-associated macrophages and cancer chemotherapy
Irina Larionova et al.
ONCOIMMUNOLOGY (2019)
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
Barbara Bassani et al.
CANCERS (2019)
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Sudha Suriyamurthy et al.
CANCERS (2019)
Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
Edo Kon et al.
DRUG RESISTANCE UPDATES (2019)
Re-education of macrophages as a therapeutic strategy in cancer
Joanna Kowal et al.
IMMUNOTHERAPY (2019)
High expression of CD47 in triple negative breast cancer is associated with epithelial-mesenchymal transition and poor prognosis
Jingping Yuan et al.
ONCOLOGY LETTERS (2019)
Deciphering the Roles of Innate Lymphoid Cells in Cancer
Melanie Bruchard et al.
FRONTIERS IN IMMUNOLOGY (2019)
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
Antonino Bruno et al.
FRONTIERS IN IMMUNOLOGY (2019)
Innate Lymphoid Cells in Mucosal Immunity
Santosh K. Panda et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
Maria Serena Roca et al.
JOURNAL OF CLINICAL MEDICINE (2019)
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging-A Literature Review
Gabrielle Planes-Laine et al.
CANCERS (2019)
Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer
Leandro M. Martinez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Karoline Kielbassa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players
Norahayu Othman et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells
Wanfeng Gao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer
Vanessa Barriga et al.
CANCERS (2019)
The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie et al.
MOLECULAR CANCER (2019)
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer A Phase 1 Study
Leisha A. Emens et al.
JAMA ONCOLOGY (2019)
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina M. Paluskievicz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
Hauke Stamm et al.
ONCOIMMUNOLOGY (2019)
Immunotherapy: A Challenge of Breast Cancer Treatment
Marilina Garcia-Aranda et al.
CANCERS (2019)
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
Laura Lorenzo-Sanz et al.
CANCER MICROENVIRONMENT (2019)
Opposing roles of eosinophils in cancer
Sonja C. S. Simon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer
Huijun Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogens and Its Receptors Into Cancer Physiopathology
Mariana Segovia-Mendoza et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
New emerging targets in cancer immunotherapy: the role of TIM3
Alex Friedlaender et al.
ESMO OPEN (2019)
Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
Samaneh Arab et al.
IMMUNE NETWORK (2019)
Tissue-specific tumor microenvironments influence responses to immunotherapies
Amanda J. Oliver et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study
Se Hyun Peek et al.
JOURNAL OF BREAST CANCER (2019)
Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance
Bastian Doersam et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Eosinophils: The unsung heroes in cancer?
Gilda Varricchi et al.
ONCOIMMUNOLOGY (2018)
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
Elisabetta Bolli et al.
ONCOIMMUNOLOGY (2018)
Activated innate lymphoid cell populations accumulate in human tumour tissues
Maryam Salimi et al.
BMC CANCER (2018)
Tumor infiltrating lymphocytes in early breast cancer
Giancarlo Pruneri et al.
BREAST (2018)
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Theodore S. Nowicki et al.
CANCER JOURNAL (2018)
Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis
Fei Xing et al.
CANCER RESEARCH (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Jeremy Force et al.
CLINICAL BREAST CANCER (2018)
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer
Antonino Bruno et al.
FASEB JOURNAL (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
Jooeun Bae et al.
LEUKEMIA (2018)
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
Wei Yan et al.
NATURE CELL BIOLOGY (2018)
Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer
Gaochen Lan et al.
ONCOLOGY LETTERS (2018)
Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer
Angelica Aponte-Lopez et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
Kristina Witt et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
Gaetano Donofrio et al.
ONCOIMMUNOLOGY (2018)
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
Alexandra Thomas et al.
ONCOIMMUNOLOGY (2018)
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Kim Ohl et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD11c-Positive Dendritic Cells in Triple-negative Breast Cancer
Heejae Lee et al.
IN VIVO (2018)
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Damien Bertheloot et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
On the origin of myeloid-derived suppressor cells
Camilla Rydberg Millrud et al.
ONCOTARGET (2017)
Tumor-associated macrophages: implications in cancer immunotherapy
Amy J. Petty et al.
IMMUNOTHERAPY (2017)
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
Nicholas A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus
Amali E. Samarasinghe et al.
JOURNAL OF IMMUNOLOGY (2017)
Barrier-tissue macrophages: functional adaptation to environmental challenges
Allan Mcl Mowat et al.
NATURE MEDICINE (2017)
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S. Karagiannis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
Azharuddin Sajid Syed Khaja et al.
ONCOTARGET (2017)
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
Xixi Zhao et al.
ONCOTARGET (2017)
PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression
Philippe Foubert et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
Viriya Kaewkangsadan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Are Mast Cells MASTers in Cancer?
Gilda Varricchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
NK cells control breast cancer and related cancer stem cell hematological spread
Rossana Tallerico et al.
ONCOIMMUNOLOGY (2017)
LAG-3+tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+tumors
S. Burugu et al.
ANNALS OF ONCOLOGY (2017)
Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
Charli Dominguez et al.
JCI INSIGHT (2017)
Innate lymphoid cells: major players in inflammatory diseases
Mikael Ebbo et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
Hye Min Kim et al.
BMC CANCER (2017)
Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer
A. -S. Hamy et al.
ANNALS OF ONCOLOGY (2017)
Understanding Interleukin 33 and Its Roles in Eosinophil Development
Laura K. Johnston et al.
FRONTIERS IN MEDICINE (2017)
Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression
Liliana Czernek et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2017)
RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers
Sheeba Irshad et al.
CANCER RESEARCH (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Immunosuppression of breast cancer cells mediated by transforming growth factor-beta in exosomes from cancer cells
Lei Rong et al.
ONCOLOGY LETTERS (2016)
Cellular analysis of the histamine H4 receptor in human myeloid cells
Ricardo Capelo et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Dongjun Peng et al.
CANCER RESEARCH (2016)
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Saida Dadi et al.
CELL (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Human innate lymphoid cells
Jenny Mjosberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer
Jithendra Kini Bailur et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
Thomas Welte et al.
NATURE CELL BIOLOGY (2016)
Innate lymphoid cell function in the context of adaptive immunity
Jennifer K. Bando et al.
NATURE IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Eosinophils in Helminth Infection: Defenders and Dupes
Lu Huang et al.
TRENDS IN PARASITOLOGY (2016)
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
Tae-Hwe Heo et al.
ONCOTARGET (2016)
A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
Xilin Chen et al.
ONCOTARGET (2016)
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
Chunwan Lu et al.
ONCOIMMUNOLOGY (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Maria Luque-Cabal et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2016)
Role of mast cells in trauma and neuroinflammation in allergy immunology
Marianne Frieri et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2015)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
Haiming Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell
Feng Xie et al.
CANCER LETTERS (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype
Meng Xu et al.
JOURNAL OF IMMUNOLOGY (2015)
Mast cell progenitors: Origin, development and migration to tissues
Joakim S. Dahlin et al.
MOLECULAR IMMUNOLOGY (2015)
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
Rafael Carretero et al.
NATURE IMMUNOLOGY (2015)
CD47 blockade as another immune checkpoint therapy for cancer
Robert H. Vonderheide
NATURE MEDICINE (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
Innate lymphoid cells: A new paradigm in immunology
Gerard Eberl et al.
SCIENCE (2015)
Characterization of tumor infiltrating Natural Killer cell subset
Inbar Levi et al.
ONCOTARGET (2015)
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
Kirsten Ridder et al.
ONCOIMMUNOLOGY (2015)
Peritumoral eosinophils predict recurrence in colorectal cancer
Lars Harbaum et al.
MODERN PATHOLOGY (2015)
The brave new world of innate lymphoid cells
Gérard Eberl et al.
NATURE IMMUNOLOGY (2014)
Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
Zoran Gatalica et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity
Shahnawaz Imam et al.
ENDOCRINE-RELATED CANCER (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB
Amy Chow et al.
SCIENTIFIC REPORTS (2014)
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
Laura Conti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells
Laura Conti et al.
FASEB JOURNAL (2013)
Targeting tumor-infiltrating macrophages to combat cancer
Roheena Z. Panni et al.
IMMUNOTHERAPY (2013)
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Georg Gasteiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
Paula D. Bos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Antonino Bruno et al.
NEOPLASIA (2013)
Stem Cell Factor Programs the Mast Cell Activation Phenotype
Tomonobu Ito et al.
JOURNAL OF IMMUNOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells
Binqing Fu et al.
IMMUNOLOGY (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
Max Yan et al.
BREAST CANCER RESEARCH (2011)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2
Francescopaolo Granata et al.
JOURNAL OF IMMUNOLOGY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Maturation of mouse NK cells is a 4-stage developmental program
Laura Chiossone et al.
BLOOD (2009)
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
Alain P. Vicari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
Aikaterini Detoraki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Eosinophil Cationic Protein (ECP) Is Processed during Secretion
Charlotte Woschnagg et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
Eva U. Wieckowski et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Shida Yousefi et al.
NATURE MEDICINE (2008)
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
Ashish B. Rajput et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking
Petra Schratl et al.
JOURNAL OF IMMUNOLOGY (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?
L Arnould et al.
BRITISH JOURNAL OF CANCER (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Distinct epigenetic changes in the stromal cells of breast cancers
M Hu et al.
NATURE GENETICS (2005)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis
S Dabiri et al.
MODERN PATHOLOGY (2004)
Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec™)
M Samoszuk et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas
M Iwamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
